MEDP

Oct 21, 4:40 PMMedpace beats Q3 2026 estimates with GAAP EPS $4.84, revenue $716.0M, guides 2026 revenue to $2.84-$2.86B, announces $1.0B buyback

Peers: ICLR IQV FTRE LH CRL TMO VEEV TEM CERT AZTA

| Held by: IJH VTI VB XMHQ VBK VXF IBB MDY IJK IWP

Scroll to Statements

Index	-
Market Cap	18.19B
Enterprise Value	17.63B
Income	517.83M
Sales	2.84B
Book/sh	20.97
Cash/sh	25.27
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	6200
IPO	Aug 11, 2016

P/E	36.15
Forward P/E	33.14
PEG	2.64
P/S	6.41
P/B	31.09
P/C	25.79
P/FCF	27.25
EV/EBITDA	27.79
EV/Sales	6.21
Quick Ratio	0.73
Current Ratio	0.83
Debt/Eq	0.25
LT Debt/Eq	0.25
Option/Short	Yes / Yes

EPS (ttm)	18.03
EPS next Y	19.67
EPS next Q	4.80
EPS this Y	18.15%
EPS next Y	8.96%
EPS next 5Y	12.54%
EPS past 3/5Y	28.02% 31.79%
Sales past 3/5Y	20.12% 22.27%
EPS Y/Y TTM	25.24%
Sales Y/Y TTM	20.35%
EPS Q/Q	25.50%
Sales Q/Q	8.50%
Earnings	Oct 21 AMC
EPS/Sales Surpr.	9.11% 0.21%

Insider Own	18.79%
Insider Trans	-6.31%
Inst Own	89.28%
Inst Trans	2.22%
ROA	25.54%
ROE	117.88%
ROIC	70.84%
Gross Margin	28.18%
Oper. Margin	21.39%
Profit Margin	18.24%
SMA20	5.08%
SMA50	6.67%
SMA200	23.56%
Trades

Shs Outstand	27.90M
Shs Float	22.67M
Short Float	7.04%
Short Ratio	5.48
Short Interest	1.60M
52W High	684.52 -4.78%
52W Low	373.00 74.75%
Volatility	4.72% 3.54%
ATR (14)	20.73
RSI (14)	62.89
Beta	1.13
Rel Volume	0.04
Avg Volume	291.36K
Volume	516

Perf Week	5.39%
Perf Month	5.03%
Perf Quarter	10.59%
Perf Half Y	58.77%
Perf YTD	16.05%
Perf Year	9.25%
Perf 3Y	186.48%
Perf 5Y	248.48%
Perf 10Y	1982.43%
Recom	2.94
Target Price	657.58
Prev Close	653.96
Price	651.80
Change %	-0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-26	Resumed	UBS	Neutral	$673
Jul-08-26	Downgrade	Robert W. Baird	Outperform → Neutral	$547
Jul-07-26	Downgrade	Jefferies	Buy → Hold	$515
Mar-06-26	Upgrade	Barclays	Underweight → Equal Weight	$500
Mar-03-26	Initiated	RBC Capital Mkts	Outperform	$522
Feb-18-26	Upgrade	TD Cowen	Sell → Hold	$419
Feb-13-26	Upgrade	Jefferies	Hold → Buy	$560
Feb-10-26	Upgrade	Robert W. Baird	Neutral → Outperform	$564
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$600
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight	$425
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$474
Jul-29-25	Downgrade	UBS	Neutral → Sell	$305
Jul-23-25	Downgrade	TD Cowen	Hold → Sell	$366
Jun-24-25	Initiated	Barclays	Equal Weight	$300
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold	$328
Mar-24-25	Initiated	Leerink Partners	Market Perform	$330
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral	$413 → $349
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral	$420 → $350

Show Previous Ratings

Oct-22-26 06:34PM	Medpace Beats And Raises Profit Outlook As Record Bookings Offset A Sharp Revenue Slowdown (Earnings Whispers)
Oct-21-26 05:33PM	Medpace beats Q3 estimates but guides below on revenue (Investing.com) +6.43%
04:28PM	Medpace: Q3 Earnings Snapshot (Associated Press)
04:15PM	Medpace Holdings, Inc. Reports Third Quarter 2026 Results (Business Wire)
Sep-22-26 04:05PM	Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026 (Business Wire)
08:01AM	Loading…
Aug-13-26 08:01AM	This Healthcare Services Stock Has 37% Upside (Barrons.com)
Jul-23-26 05:00PM	Medpace Holdings Inc (MEDP) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Record ... (GuruFocus.com) +14.71%
Jul-22-26 04:42PM	Medpace: Q2 Earnings Snapshot (Associated Press)
04:15PM	Medpace Holdings, Inc. Reports Second Quarter 2026 Results (Business Wire)
Jul-08-26 09:39AM	Dollar Tree upgraded, PayPal initiated: Wall Street's top analyst calls (The Fly)
Jul-07-26 09:36AM	SpaceX initiated, Cloudflare upgraded: Wall Street's top analyst calls (The Fly)
Jun-16-26 04:23PM	Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026 (Business Wire)
Jun-01-26 03:51AM	Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP (PR Newswire)
Apr-24-26 03:09AM	Medpace Holdings Inc (MEDP) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Rising ... (GuruFocus.com)
Apr-22-26 04:59PM	Medpace: Q1 Earnings Snapshot (Associated Press) -22.63%
04:15PM	Loading…
04:15PM	Medpace Holdings, Inc. Reports First Quarter 2026 Results (Business Wire)
Apr-14-26 04:36AM	Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP (PR Newswire)
Apr-10-26 07:51AM	Shareholders who lost money in Medpace Holdings, Inc. (NASDAQ: MEDP) Should Contact Wolf Haldenstein Immediately (PR Newswire)
Apr-07-26 10:36AM	Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights MEDP (Business Wire)
Mar-24-26 04:05PM	Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026 (Business Wire)
Mar-09-26 06:15PM	Medpace (MEDP) Outpaces Stock Market Gains: What You Should Know (Zacks)
Mar-06-26 08:30AM	Do Options Traders Know Something About Medpace Stock We Don't? (Zacks)
Mar-05-26 11:40AM	PACS vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
Mar-04-26 05:51PM	COWG Is Up While QQQ Slips. What the Free Cash Flow Screen Is Actually Doing (24/7 Wall St.)
Mar-03-26 09:33AM	MongoDB downgraded, Block upgraded: Wall Street's top analyst calls (The Fly)
Mar-02-26 06:45PM	Analyst Report: Medpace Holdings, Inc. (Morningstar Research)
Mar-01-26 10:34PM	Medpace (NASDAQ:MEDP): Strongest Q4 Results from the Drug Development Inputs & Services Group (StockStory)
Feb-26-26 06:15PM	Medpace (MEDP) Rises As Market Takes a Dip: Key Facts (Zacks)
Feb-23-26 12:00PM	Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know (StockStory)
Feb-18-26 09:50AM	Palantir upgraded, Workday downgraded: Wall Street's top analyst calls (The Fly)
08:18AM	Loading…
08:18AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: Cadence Design, Crox, Genuine Parts, Kratos Defense, Medtronic, Palantir, StubHub, Transocean, and More (24/7 Wall St.)
Feb-16-26 12:31AM	The 5 Most Interesting Analyst Questions From Medpace's Q4 Earnings Call (StockStory)
Feb-15-26 08:32AM	Pinterest, DraftKings, And Flutter Are Among Top 10 Large Cap Losers Last Week (Feb. 9-Feb. 13): Are the Others in Your Portfolio? (Benzinga)
Feb-11-26 07:24PM	Analyst Report: Medpace Holdings, Inc. (Morningstar Research)
Feb-10-26 07:38PM	Analyst Report: Medpace Holdings, Inc. (Morningstar Research) -15.90%
04:09PM	The 'Key Negative' That Took Out Medpace's Sales, Profit Beat (Investor's Business Daily)
04:00PM	Medpace Holdings Inc (MEDP) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
03:50PM	Medpace Q4 Earnings Call Highlights (MarketBeat)
01:11PM	Dow Jones Reaches Record Highs, Software Stocks Extend Rebound: What's Moving Markets Tuesday? (Benzinga)
10:35AM	MEDP Q4 Deep Dive: Cancellations and Metabolic Trial Mix Pressure Margins Despite Strong Growth (StockStory)
Feb-09-26 05:25PM	Medpace (MEDP) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:31PM	Medpace (NASDAQ:MEDP) Reports Bullish Q4 CY2025 (StockStory)
04:21PM	Medpace: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-07-26 10:01PM	Earnings To Watch: Medpace (MEDP) Reports Q4 Results Tomorrow (StockStory)
Jan-30-26 06:15PM	Medpace (MEDP) Declines More Than Market: Some Information for Investors (Zacks)
09:06AM	Here's Why Medpace (MEDP) Shares Roared in 2025 (Insider Monkey)
Jan-23-26 06:15PM	Medpace (MEDP) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
08:34AM	Vulcan Value Partners' Thoughts on Medpace Holdings (MEDP) (Insider Monkey)
Jan-17-26 11:37AM	S&P 500 Financial Titan BlackRock Leads Five Stocks To Watch (Investor's Business Daily)
Jan-16-26 12:19PM	Stock Market Today: Indexes Higher Amid Trump's Remarks On Next Fed Chair; Biotech Breaks Out (Live Coverage) (Investor's Business Daily)
Jan-15-26 11:02PM	Medpace (MEDP): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Jan-14-26 06:15PM	Why the Market Dipped But Medpace (MEDP) Gained Today (Zacks)
Jan-13-26 05:12PM	IBD Stock Of The Day Medpace Tests Early Buy Point As Biotech Funding Shines (Investor's Business Daily)
Jan-12-26 10:07AM	Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny (Zacks)
09:56AM	GeneDx Partners With Komodo Health to Advance Rare Disease Research (Zacks)
Jan-09-26 10:53AM	SENS Stock Up as Eversense 365 Enters AID Market With twiist System (Zacks)
09:04AM	3 Medical Service Industry Stocks Set to Tackle Workforce Challenges (Zacks)
Jan-08-26 06:15PM	Medpace (MEDP) Stock Dips While Market Gains: Key Facts (Zacks)
08:29AM	Here's Why You Should Hold Avantor Stock in Your Portfolio for Now (Zacks)
07:57AM	Here's Why You Should Retain Cencora Stock in Your Portfolio Now (Zacks)
Jan-07-26 12:11PM	ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 12:34PM	CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection (Zacks)
07:05AM	OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth (Zacks)
Jan-05-26 04:05PM	Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026 (Business Wire)
Jan-02-26 11:36AM	INBS Stock Surges 132.4% on New Manufacturing Partnership (Zacks)
08:33AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
Dec-31-25 06:15PM	Why Medpace (MEDP) Dipped More Than Broader Market Today (Zacks)
10:52AM	Reasons to Hold HealthEquity Stock in Your Portfolio for Now (Zacks)
10:49AM	CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform (Zacks)
Dec-30-25 12:45PM	ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction (Zacks)
Dec-29-25 11:42AM	Reasons to Hold Veeva Systems Stock in Your Portfolio for Now (Zacks)
Dec-26-25 11:40AM	BTSG or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
Dec-24-25 12:29PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
Dec-23-25 12:07PM	BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens (Zacks)
06:30AM	Strategists are bullish on healthcare in 2026: 3 top stock picks (Yahoo Finance Video)
Dec-22-25 07:51AM	Here's Why You Should Retain INSP Stock in Your Portfolio Now (Zacks)
Dec-19-25 06:15PM	Medpace (MEDP) Outperforms Broader Market: What You Need to Know (Zacks)
10:25AM	PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial (Zacks)
08:41AM	Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica (Zacks)
Dec-18-25 11:00AM	ECL Boosts High-Tech Water Platform With Ovivo's Electronics Business (Zacks)
09:07AM	Here's Why You Should Hold DaVita Stock in Your Portfolio for Now (Zacks)
08:28AM	Here's Why You Should Retain CLOV Stock in Your Portfolio Now (Zacks)
Dec-17-25 12:02PM	GEHC Expands Healthcare Access Through Indonesia MoH Partnership Deal (Zacks)
11:58AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Dec-15-25 10:24AM	BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care (Zacks)
09:13AM	Medpace Holdings (MEDP) Surged Following the Strong Results (Insider Monkey)
Dec-12-25 10:30AM	ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform (Zacks)
09:38AM	Hims & Hers Expands Weight-Management Program to the United Kingdom (Zacks)
Dec-11-25 12:51PM	MOH, Aeroflow Team Up to Offer Virtual Diabetes Care in South Carolina (Zacks)
08:32AM	Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now (Zacks)
07:17AM	BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System (Zacks)
07:12AM	Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now (Zacks)
Dec-10-25 11:40AM	BTSG vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
08:59AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
08:05AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
Dec-09-25 09:00AM	What Makes Medpace Holdings (MEDP) an Investment Choice? (Insider Monkey)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BURWIG SUSAN E	Exec. VP, Operations	Oct 12 '26	Option Exercise	166.73	3,000	500,190	70,984	Oct 14 04:14 PM
BURWIG SUSAN E	Exec. VP, Operations	Oct 07 '26	Option Exercise	166.73	2,000	333,460	67,984	Oct 09 04:14 PM
Troendle August J.	President & CEO	Sep 29 '26	Sale	621.02	26,701	16,581,855	360,191	Oct 01 05:43 PM
Troendle August J.	President & CEO	Sep 30 '26	Sale	625.47	21,966	13,739,074	338,225	Oct 01 05:43 PM
Troendle August J.	President & CEO	Sep 28 '26	Sale	620.07	2,410	1,494,369	386,892	Sep 29 04:13 PM
Troendle August J.	President & CEO	Sep 25 '26	Sale	620.60	154	95,572	389,302	Sep 29 04:13 PM
Troendle August J.	President & CEO	Sep 24 '26	Sale	621.33	27,833	17,293,478	389,456	Sep 25 04:22 PM
Troendle August J.	President & CEO	Sep 23 '26	Sale	628.64	16,083	10,110,417	417,289	Sep 25 04:22 PM
Troendle August J.	President & CEO	Sep 22 '26	Sale	628.11	49,018	30,788,696	433,372	Sep 23 04:05 PM
Troendle August J.	President & CEO	Sep 21 '26	Sale	623.29	21,883	13,639,455	482,390	Sep 23 04:05 PM
Troendle August J.	President & CEO	Sep 17 '26	Sale	620.40	10,880	6,749,952	504,273	Sep 21 04:23 PM
Troendle August J.	President & CEO	Sep 15 '26	Sale	620.84	15,971	9,915,436	523,923	Sep 17 04:39 PM
Troendle August J.	President & CEO	Sep 16 '26	Sale	621.29	8,770	5,448,713	515,153	Sep 17 04:39 PM
BURWIG SUSAN E	Exec. VP, Operations	Sep 15 '26	Option Exercise	166.73	3,000	500,190	65,984	Sep 17 04:35 PM
Troendle August J.	President & CEO	Aug 27 '26	Sale	620.27	650	403,176	539,894	Aug 31 04:11 PM
Kraft Robert O.	Director	Aug 26 '26	Option Exercise	84.36	3,858	325,461	4,813	Aug 28 04:32 PM
Kraft Robert O.	Director	Aug 26 '26	Sale	617.81	3,858	2,383,511	955	Aug 28 04:32 PM
Troendle August J.	President & CEO	Aug 26 '26	Sale	620.03	4,000	2,480,120	540,544	Aug 27 04:12 PM
Troendle August J.	President & CEO	Aug 25 '26	Sale	620.38	673	417,516	544,544	Aug 27 04:12 PM
Kraft Robert O.	Director	Aug 26 '26	Proposed Sale	617.81	3,858	2,383,522		Aug 26 02:43 PM
Troendle August J.	President & CEO	Aug 21 '26	Sale	624.45	13,995	8,739,178	547,200	Aug 25 04:24 PM
Troendle August J.	President & CEO	Aug 24 '26	Sale	620.23	1,983	1,229,916	545,217	Aug 25 04:24 PM
Brady Kevin M.	CFO & Treasurer	Aug 20 '26	Option Exercise	138.87	3,400	472,158	16,230	Aug 24 04:27 PM
Brady Kevin M.	CFO & Treasurer	Aug 20 '26	Sale	625.24	3,400	2,125,816	12,830	Aug 24 04:27 PM
Troendle August J.	President & CEO	Aug 20 '26	Sale	618.79	27,174	16,814,999	561,195	Aug 21 04:13 PM
Troendle August J.	President & CEO	Aug 19 '26	Sale	606.47	15,609	9,466,390	588,369	Aug 21 04:13 PM
Carley Brian T	Director	Aug 19 '26	Sale	608.63	5,000	3,043,150	27,825	Aug 21 04:12 PM
DAVENPORT FRED B JR	Director	Aug 19 '26	Option Exercise	116.08	7,583	880,262	11,081	Aug 21 04:11 PM
DAVENPORT FRED B JR	Director	Aug 19 '26	Sale	606.15	7,283	4,414,590	3,798	Aug 21 04:11 PM
Brady Kevin M.	Officer	Aug 20 '26	Proposed Sale	625.24	3,400	2,125,816		Aug 20 03:19 PM
Carley Brian T	Director	Aug 19 '26	Proposed Sale	608.63	5,000	3,043,155		Aug 19 04:41 PM
DAVENPORT FRED B JR	Director	Aug 19 '26	Proposed Sale	606.15	7,283	4,414,616		Aug 19 02:45 PM
Troendle August J.	President & CEO	Aug 12 '26	Sale	601.53	11,366	6,836,990	604,436	Aug 14 04:18 PM
Troendle August J.	President & CEO	Aug 13 '26	Sale	600.39	458	274,979	603,978	Aug 14 04:18 PM
McCarthy Cornelius P. III	Director	Aug 11 '26	Sale	605.37	1,140	690,122	12,275	Aug 13 04:12 PM
Troendle August J.	President & CEO	Aug 11 '26	Sale	605.11	17,610	10,655,987	615,802	Aug 12 04:28 PM
Troendle August J.	President & CEO	Aug 10 '26	Sale	601.53	5,534	3,328,867	633,412	Aug 12 04:28 PM
McCarthy Cornelius P. III	Director	Aug 11 '26	Proposed Sale	605.37	1,140	690,122		Aug 11 05:01 PM
McCarthy Cornelius P. III	Director	Aug 07 '26	Option Exercise	84.36	3,858	325,461	14,210	Aug 11 04:09 PM
McCarthy Cornelius P. III	Director	Aug 07 '26	Sale	585.07	795	465,131	13,415	Aug 11 04:09 PM
McCarthy Cornelius P. III	Director	Aug 07 '26	Proposed Sale	585.07	795	465,131		Aug 07 02:57 PM
Troendle August J.	President & CEO	Jul 27 '26	Sale	600.85	3,728	2,239,969	642,456	Jul 29 04:36 PM
Troendle August J.	President & CEO	Jul 28 '26	Sale	600.01	3,510	2,106,035	638,946	Jul 29 04:36 PM
BURWIG SUSAN E	Exec. VP, Operations	Jul 28 '26	Sale	600.00	7,500	4,500,000	62,984	Jul 29 04:32 PM
BURWIG SUSAN E	Officer	Jul 28 '26	Proposed Sale	600.00	7,500	4,500,000		Jul 28 01:32 PM
GEIGER JESSE J	Former Officer	Jul 28 '26	Proposed Sale	600.00	4,000	2,400,000		Jul 28 11:00 AM
August J. Troendle	Chairman	Jul 27 '26	Proposed Sale	600.00	307,959	184,775,400		Jul 27 04:52 PM
GEIGER JESSE J	Former Officer	Jul 23 '26	Proposed Sale	631.90	11,000	6,950,878		Jul 23 04:17 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	May 28 '26	Option Exercise	138.87	16,349	2,270,386	36,692	Jun 01 04:27 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	May 28 '26	Sale	450.00	16,349	7,357,050	20,343	Jun 01 04:27 PM
EWALD STEPHEN P	Officer	May 28 '26	Proposed Sale	450.00	16,349	7,357,050		May 28 04:07 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Apr 24 '26	Option Exercise	138.87	3,500	486,045	20,343	Apr 28 04:51 PM
Brady Kevin M.	CFO & Treasurer	Apr 24 '26	Option Exercise	138.87	7,000	972,090	12,830	Apr 28 04:42 PM
BURWIG SUSAN E	Exec. VP, Operations	Mar 18 '26	Option Exercise	166.73	12,000	2,000,760	70,484	Mar 19 04:50 PM
GEIGER JESSE J	President	Mar 17 '26	Option Exercise	138.87	31,707	4,403,151	46,707	Mar 19 04:45 PM
GEIGER JESSE J	President	Mar 17 '26	Sale	455.30	31,707	14,436,197	15,000	Mar 19 04:45 PM
GEIGER JESSE J	Officer	Mar 17 '26	Proposed Sale	457.75	31,707	14,513,879		Mar 17 12:37 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Feb 17 '26	Option Exercise	138.87	3,500	486,045	16,843	Feb 18 04:59 PM
Carley Brian T	Director	Feb 13 '26	Option Exercise	54.99	6,472	355,895	32,753	Feb 17 04:59 PM
BURWIG SUSAN E	Exec. VP, Operations	Feb 13 '26	Option Exercise	107.93	10,984	1,185,503	58,484	Feb 17 04:43 PM
BURWIG SUSAN E	Exec. VP, Operations	Dec 05 '25	Option Exercise	107.93	10,000	1,079,300	47,500	Dec 09 04:14 PM
Troendle August J.	CEO	Dec 03 '25	Sale	590.69	668	394,581	646,184	Dec 04 04:26 PM
BURWIG SUSAN E	Exec. VP, Operations	Dec 02 '25	Option Exercise	107.93	10,000	1,079,300	37,500	Dec 04 04:21 PM
Troendle August J.	CEO	Dec 01 '25	Sale	593.25	23,178	13,750,348	652,550	Dec 03 04:28 PM
Troendle August J.	CEO	Dec 02 '25	Sale	590.47	5,698	3,364,498	646,852	Dec 03 04:28 PM
Troendle August J.	CEO	Nov 26 '25	Sale	606.88	41,331	25,082,957	690,879	Dec 01 04:48 PM
Troendle August J.	CEO	Nov 28 '25	Sale	593.46	15,151	8,991,512	675,728	Dec 01 04:48 PM
Troendle August J.	CEO	Nov 24 '25	Sale	607.78	59,025	35,874,214	774,602	Nov 26 04:29 PM
Troendle August J.	CEO	Nov 25 '25	Sale	615.52	42,392	26,093,124	732,210	Nov 26 04:29 PM
BURWIG SUSAN E	Exec. VP, Operations	Nov 24 '25	Sale	609.15	20,000	12,183,000	27,500	Nov 26 04:22 PM
August J. Troendle	Chairman	Nov 25 '25	Proposed Sale	615.00	150,000	92,250,000		Nov 25 04:43 PM
Brady Kevin M.	CFO & Treasurer	Nov 21 '25	Option Exercise	166.73	3,000	500,190	9,000	Nov 25 04:40 PM
Brady Kevin M.	CFO & Treasurer	Nov 21 '25	Sale	590.35	3,000	1,771,050	6,000	Nov 25 04:40 PM
Troendle August J.	CEO	Nov 21 '25	Sale	592.18	21,858	12,943,870	833,627	Nov 24 04:20 PM
Troendle August J.	CEO	Nov 20 '25	Sale	598.49	6,830	4,087,687	855,485	Nov 24 04:20 PM
BURWIG SUSAN E	Officer	Nov 24 '25	Proposed Sale	609.15	20,000	12,183,035		Nov 24 02:03 PM
Brady Kevin M.	Officer	Nov 21 '25	Proposed Sale	590.35	3,000	1,771,051		Nov 21 01:43 PM
Troendle August J.	CEO	Nov 19 '25	Sale	592.07	23,862	14,127,974	862,315	Nov 20 04:14 PM
Troendle August J.	CEO	Nov 18 '25	Sale	590.84	7,191	4,248,730	886,177	Nov 20 04:14 PM
Kraft Robert O.	Director	Nov 14 '25	Option Exercise	54.99	6,472	355,895	7,305	Nov 18 05:02 PM
Kraft Robert O.	Director	Nov 14 '25	Sale	591.85	6,472	3,830,453	833	Nov 18 05:02 PM
Troendle August J.	CEO	Nov 14 '25	Sale	595.26	14,747	8,778,299	899,415	Nov 18 04:51 PM
Troendle August J.	CEO	Nov 17 '25	Sale	591.00	6,047	3,573,777	893,368	Nov 18 04:51 PM
Troendle August J.	CEO	Nov 12 '25	Sale	603.23	5,312	3,204,358	919,290	Nov 14 04:41 PM
Troendle August J.	CEO	Nov 13 '25	Sale	601.37	5,128	3,083,825	914,162	Nov 14 04:41 PM
Kraft Robert O.	Director	Nov 14 '25	Proposed Sale	591.85	6,472	3,830,434		Nov 14 04:12 PM
August J. Troendle	Chairman	Nov 12 '25	Proposed Sale	600.00	150,000	90,000,000		Nov 12 04:53 PM
BURWIG SUSAN E	Exec. VP, Operations	Nov 11 '25	Sale	605.00	18,000	10,890,000	47,500	Nov 12 10:10 AM
BURWIG SUSAN E	Officer	Nov 11 '25	Proposed Sale	605.00	18,000	10,890,000		Nov 12 07:52 AM
GEIGER JESSE J	President	Nov 05 '25	Sale	595.66	21,503	12,808,477	15,000	Nov 07 04:38 PM
GEIGER JESSE J	Officer	Nov 05 '25	Proposed Sale	595.66	21,503	12,808,442		Nov 05 04:20 PM
DAVENPORT FRED B JR	Director	Oct 30 '25	Option Exercise	54.99	6,472	355,895	9,470	Nov 03 04:46 PM
DAVENPORT FRED B JR	Director	Oct 30 '25	Sale	581.88	5,972	3,474,987	3,498	Nov 03 04:46 PM
DAVENPORT FRED B JR	Director	Oct 30 '25	Proposed Sale	581.88	5,972	3,474,993		Oct 30 10:38 AM
GEIGER JESSE J	President	Oct 27 '25	Option Exercise	166.73	19,460	3,244,566	55,963	Oct 29 05:12 PM
GEIGER JESSE J	President	Oct 29 '25	Option Exercise	166.73	3,568	594,893	40,071	Oct 29 05:12 PM
GEIGER JESSE J	President	Oct 27 '25	Sale	605.12	19,460	11,775,635	36,503	Oct 29 05:12 PM
GEIGER JESSE J	President	Oct 29 '25	Sale	585.00	3,568	2,087,280	36,503	Oct 29 05:12 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Oct 27 '25	Option Exercise	166.73	18,230	3,039,488	28,573	Oct 29 04:58 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Oct 27 '25	Sale	598.85	15,230	9,120,486	13,343	Oct 29 04:58 PM

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: North America, Europe, Asia, South America, Africa and Australia. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

CEODr. August James Troendle M.D.

Chief Compliance OfficerMr. Stephen P. Ewald J.D.

Executive Vice President of OperationsMr. Brad W. Hansman

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Medpace Holdings Inc

Upgrade your Finviz experience